This archive collects 72 stories tracking real progress made during and after the COVID-19 pandemic — from vaccine development and public health responses to community resilience and scientific cooperation. Each article focuses on what worked, what was learned, and how those lessons are shaping a more prepared world.
The West African nations each received more than half a million doses. The deliveries signify the launch of the largest, most rapid and complex global vaccine rollout in history, said WHO.
The foundation, which grew out of the creation of the Black Lives Matter movement nearly eight years ago, plans to give 3,000 microgrants of $1,000 each to people who it believes need it most.
The platform’s new pandemic specifics allow customers to report if staff and other customers are following social distancing and mask protocols.
New Zealand Foreign Affairs Minister Hon Nanaia Mahuta confirmed NZD $75 million of assistancehad been earmarked to support Pacific and global vaccine access and roll-out.
EU lawmakers agreed to provide a €672 billion recovery fund boost for the EU economy. 37% of the funding has to go to projects that help the climate.
The Africa Infodemic Response Alliance (AIRA), brings together 13 international and regional organizations, together with fact-checking groups which have expertise in data and behavioural science, epidemiology, research, digital health and communications.
Over 41,000 people had completed the vaccination protocol. Out of the 170 positive COVID cases detected in the trial only eight were observed in the active vaccine group.
Unique new research is looking at the effects of UBI during a pandemic by analyzing data from a massive ongoing 12-year income study in Kenya, and its conclusion suggests the policy may help individual well-being but it is not a silver-bullet solution in times of extreme disruption.
Over the last two decades, Gavi has helped to immunize a whole generation – over 822 million children – and prevented more than 14 million deaths, helping to halve child mortality in 73 developing countries.
The US Food and Drug Administration (FDA) set a minimum effectiveness bar for COVID-19 vaccines at 50% for drugs seeking approval. This is the first COVID-19 candidate vaccine to produce data exceeding that mark.
